Target intelligence / Profile preview

Superoxide dismutase 1 pseudogene 3 (SOD1P3)

Target: SOD1P3
Molecular classification: Other (pseudogene)

Overview

Superoxide dismutase 1 pseudogene 3 (SOD1P3) is a non-functional gene sequence classified as a pseudogene, sharing sequence similarity with the enzyme-encoding SOD1 gene but lacking known protein-coding potential or biological function. Unlike the canonical SOD1 gene—responsible for antioxidant activity and mutated in diseases such as amyotrophic lateral sclerosis (ALS)—SOD1P3 does not encode a functional protein and currently is not associated with any disease role, drug interaction, or biomarker utility. There is no evidence categorizing SOD1P3 as a therapeutic target, and it is not considered in pharmacology or molecular therapy contexts.

Other names: Superoxide dismutase 1, soluble pseudogene 3superoxide dismutase [Cu-Zn]-likeSOD1P3

Beyond the preview

Go deeper on Superoxide dismutase 1 pseudogene 3 (SOD1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superoxide dismutase 1 pseudogene 3 (SOD1P3).

Explore the full profile